DPP4 inhibitors and respiratory infection, a systematic review and meta-analysis of the CardioVascular Outcomes Trials conducted before the pandemic and implications for the management of diabetes during COVID-19
View ORCID ProfileGuillaume Grenet, Samia Mekhaldi, Sabine Mainbourg, Marine Auffret, Catherine Cornu, Jean-Luc Cracowski, François Gueyffier, Jean-Christophe Lega, Michel Cucherat
doi: https://doi.org/10.1101/2020.07.28.20163386
Guillaume Grenet
1Hospices Civils de Lyon, Pôle Santé Publique, Service hospitalo-universitaire de pharmacotoxicologie, Lyon, France
MDSamia Mekhaldi
2Université de Lyon, Université Lyon 1, CNRS, Laboratoire de Biométrie et Biologie Evolutive UMR 5558, F-69622 Villeurbanne, France
PharmDSabine Mainbourg
5Hospices Civils de Lyon, Hôpital Lyon Sud, Service de Médecine Interne et Vasculaire, Lyon, France
MDMarine Auffret
1Hospices Civils de Lyon, Pôle Santé Publique, Service hospitalo-universitaire de pharmacotoxicologie, Lyon, France
PharmDCatherine Cornu
2Université de Lyon, Université Lyon 1, CNRS, Laboratoire de Biométrie et Biologie Evolutive UMR 5558, F-69622 Villeurbanne, France
3CIC1407 INSERM, Hospices Civils de Lyon, Lyon, France
MDJean-Luc Cracowski
4Univ. Grenoble Alpes, INSERM, HP2, and centre régional de pharmacovigilance de Grenoble, F-38000 Grenoble, France
MDFrançois Gueyffier
2Université de Lyon, Université Lyon 1, CNRS, Laboratoire de Biométrie et Biologie Evolutive UMR 5558, F-69622 Villeurbanne, France
MDJean-Christophe Lega
5Hospices Civils de Lyon, Hôpital Lyon Sud, Service de Médecine Interne et Vasculaire, Lyon, France
MDMichel Cucherat
1Hospices Civils de Lyon, Pôle Santé Publique, Service hospitalo-universitaire de pharmacotoxicologie, Lyon, France
2Université de Lyon, Université Lyon 1, CNRS, Laboratoire de Biométrie et Biologie Evolutive UMR 5558, F-69622 Villeurbanne, France
MD
Posted July 29, 2020.
DPP4 inhibitors and respiratory infection, a systematic review and meta-analysis of the CardioVascular Outcomes Trials conducted before the pandemic and implications for the management of diabetes during COVID-19
Guillaume Grenet, Samia Mekhaldi, Sabine Mainbourg, Marine Auffret, Catherine Cornu, Jean-Luc Cracowski, François Gueyffier, Jean-Christophe Lega, Michel Cucherat
medRxiv 2020.07.28.20163386; doi: https://doi.org/10.1101/2020.07.28.20163386
DPP4 inhibitors and respiratory infection, a systematic review and meta-analysis of the CardioVascular Outcomes Trials conducted before the pandemic and implications for the management of diabetes during COVID-19
Guillaume Grenet, Samia Mekhaldi, Sabine Mainbourg, Marine Auffret, Catherine Cornu, Jean-Luc Cracowski, François Gueyffier, Jean-Christophe Lega, Michel Cucherat
medRxiv 2020.07.28.20163386; doi: https://doi.org/10.1101/2020.07.28.20163386
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (716)
- Anesthesia (210)
- Cardiovascular Medicine (2995)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12887)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4679)
- Geriatric Medicine (429)
- Health Economics (738)
- Health Informatics (2976)
- Health Policy (1080)
- Hematology (396)
- HIV/AIDS (942)
- Medical Education (436)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4465)
- Nursing (239)
- Nutrition (655)
- Oncology (2321)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1210)
- Primary Care Research (507)
- Public and Global Health (7058)
- Radiology and Imaging (1568)
- Respiratory Medicine (930)
- Rheumatology (447)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (61)
- Transplantation (214)
- Urology (186)